OQROGet OQRO Pro
Insider trade

Rein Therapeutics (RNTX)Director bought ~$24K

Rickenbach Josef H Von, Director at Rein Therapeutics, bought ~$24K of Rein Therapeutics shares.

~$24K
Approx. value · 23K sh @ $1.06
58K
Holds after · shares reported
Traded
May 26, 2026
Filed
May 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 30, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  2. Apr 30, 2026Insider · Their largest buy since 2023Director purchased ~$25K of RNTX shares in the open market
  3. May 21, 2026Insider · First buy since 2020Director purchased ~$3.6K of RNTX shares in the open market
  4. May 22, 2026InsiderDirector purchased ~$17K of RNTX shares in the open market
  5. May 26, 2026 · this disclosureInsiderDirector purchased ~$24K of RNTX shares in the open market

What came next

  1. May 27, 2026InsiderDirector purchased ~$4.8K of RNTX shares in the open market
  2. Aug 21, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On August 21, 2026, Rein Therapeutics, Inc. (“Company”) received a notice of delisting (the “Notice”) from the Nasdaq Stock Market, LLC. The Notice stated that the Company had fallen below compliance with respect to the continued listing standard set forth in Rule 5550(a)(1) of the Nasdaq Listing Rules because the closing bid price of the Company’s common stock over the previous 30 consecutive trading-day period had…”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Rein Therapeutics

OQRO holds no insider, Congress, fund or contract record for Rein Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RNTX page.

Other recent filings by Rickenbach Josef H Von, Director

The full history of Rickenbach Josef H Von, Director is on the profile page.

How this filing works

Other disclosures at Rein Therapeutics

Everything OQRO holds on this company is on its RNTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data